Evidence map›Paper›PMID 31225812›Full record

Observational studyAIDS (London, England)2019

IL-4 polymorphism influences susceptibility to Pneumocystis jirovecii pneumonia in HIV-positive patients.

Agnieszka Wójtowicz, Stéphanie Bibert, Patrick Taffé, Enos Bernasconi, Hansjakob Furrer, Huldrych F Günthard, Matthias Hoffmann, Michael Osthoff, Matthias Cavassini, Pierre-Yves Bochud and 1 more

Open access · greenAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in AIDS (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Immune Responses toJournal of inflammation research · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Observational
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Agnieszka WójtowiczDepartment of Medicine, Infectious Diseases Service.
Stéphanie BibertDepartment of Medicine, Infectious Diseases Service.
Patrick TafféInstitute for Social and Preventive Medicine, University Hospital and University of Lausanne, Lausanne.
Enos BernasconiDivision of Infectious Diseases, Regional Hospital of Lugano, Lugano.
Hansjakob FurrerDepartment of Infectious Diseases, Bern University Hospital and University of Bern, Bern.
Huldrych F GünthardDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich and University of Zürich.
Matthias HoffmannDivision of Infectious Diseases and Hospital Epidemiology, Department of Internal Medicine, Cantonal Hospital St.Gallen, St.Gallen.
Michael OsthoffDivision of Infectious Diseases and Hospital Epidemiology and Department of Internal Medicine, University Hospital Basel, Basel, Switzerland.
Matthias CavassiniDepartment of Medicine, Infectious Diseases Service.
Pierre-Yves BochudDepartment of Medicine, Infectious Diseases Service.
Swiss HIV Cohort Study
Office of Infectious Diseases · USInstitute of Social and Preventive Medicine · CHOspedale regionale di Lugano · CHUniversity Hospital of Bern · CHUniversity of St. Gallen · CHUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesPneumocystis jirovecii pneumonia (PJP) is an important cause of morbidity and mortality in HIV-positive patients. Polymorphisms in immune genes are increasingly reported to influence susceptibility to fungal infections. We analysed the role of 21 single nucleotide polymorphisms from 19 candidate genes on PJP development in patients from the Swiss HIV Cohort Study. DESIGN AND

methodsThe analysis included patients with a nadir CD4 T-cell count less than 200 cells/μl, divided into a discovery (N = 1645) and a replication (N = 1861) cohort. The associations were analysed by using cumulative incidence curves as well as competing risk regression over 18 years, starting from the estimated date of HIV infection, considering death a competing risk, with censoring at lost follow-up, and assuming the dominant mode of inheritance.

resultsThe minor allele of rs2243250 in IL-4 was associated with the risk of PJP in the discovery cohort (cumulative incidence 0.18 versus 0.12, P = 0.002). This association was replicated in the validation cohort (0.16 versus 0.12, P = 0.02). It was still significant in multivariate models, adjusted for HIV transmission mode, viral load, CD4 T cells slope, age, antiretroviral therapy, tobacco smoking, hepatitis C virus coinfection, year of cohort entry and PJP prophylaxis (global subhazard ratio 1.42, 95% confidence interval 1.17-1.73, P = 0.0004).

conclusionOur data suggest rs2243250, a single nucleotide polymorphism known to influence IL-4 production, is associated with susceptibility to PJP in HIV-positive patients.

Indexed as

Genetic Predisposition to DiseaseAdolescentAdultAgedAnti-HIV AgentsCD4 Lymphocyte CountChildFemaleGenetic Association StudiesHIV InfectionsHumansIncidenceInterleukin-4Linear ModelsMaleMiddle AgedAnti-HIV AgentsIL4 protein, humanInterleukin-4

Identifiers

PMID31225812
PMCPMC6686957
OpenAlexW2949087121

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.